To highlight the potential for this approach to couple transgene expression to CAR activation, we first cocultured anti-Lewis Y CAR T cells engineered to express NGFR under the control of the NR4A2 promoter with Lewis Y+ tumor cells. Here, NR4A2 is linked to neoplasm.